Baxter provides purified plasma treatments containing antibodies called immunoglobulins that help Primary Immune Deficiency patients fight off infection. Immunoglobulins are also indicated to treat a number of conditions including Kawasaki Syndrome, Chronic Lymphocytic Leukemia (CLL) and Idiopathic Thrombocytopenic Purpura (ITP).
Critical Care
Baxter’s vast experience in plasma fractionation has resulted in reliable and innovative therapeutics developed from human serum albumin to support these patients.
Baxter manufactures and supplies therapeutic proteins for the treatment of one of the rarer forms of thrombophilia.
Print this page
